|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/555 | (2006.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61K 31/704 | (2006.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 33/243 | (2019.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3725810 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20163993.7 |
| Date of filing the European patent application | 2013-05-21 | |
| (97) | Date of publication of the European application | 2020-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-06 |
| (46) | Date of publication of the claims translation | 2022-08-25 |
| (30) | Number | Date | Country code |
| PCT/EP2012/002211 | 2012-05-23 | WO |
| (72) |
SAHIN, Ugur , DE
TÜRECI, Özlem , DE
MITNACHT-KRAUS, Rita , DE
JACOBS, Stefan Denis , DE
UTSCH, Magdalena Jadwiga , DE
HEINZ, Cornelia Adriana Maria , DE
STADLER, Christiane Regina , DE
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-honcho 2-chome,
Chuo-ku
Tokyo 103-8411,
JP
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kombinuota terapija, apimanti antikūnus prieš klaudiną 18.2, skirta vėžio gydymui |
| COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2024-05-02 | 12 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-09-23 |